Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Reduction of Peginterferon Alfa-2a in Korean CHC Genotype 1
NCT01378104Phase 4Completed
- Sponsor
- The Catholic University of Korea
- Start
- Oct 2008
- Primary completion
- Sep 2011
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 4 trial of interferon alfa in hepatitis C (HCV), sponsored by The Catholic University of Korea. Started Oct 2008; status: completed.
02
Drugs
interferon alfa
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01378104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01378104.